Odyssey Health (ODYY) EBITDA Margin (2014 - 2016)

Odyssey Health's EBITDA Margin history runs 3 years deep, the most recent figure standing at 207.5% for Q3 2016.

• On a quarterly basis, EBITDA Margin changed N/A year-over-year to 207.5% in Q3 2016; TTM through Apr 2017 was 972.18%, a 67667.0% decrease from a year earlier, with the FY2016 full-year figure at 196.43%, down 13582.0% from the prior year.
• EBITDA Margin retreated to 207.5% in Q3 2016 per ODYY's latest filing, from 13.88% in the prior quarter.
• Across five years, EBITDA Margin topped out at 13.88% in Q2 2016 and bottomed at 235.48% in Q2 2015.
• The 3-year median for EBITDA Margin is 49.03% (2015), against an average of 106.97%.
• Biggest YoY gain for EBITDA Margin was 22159 bps in 2016; the steepest drop was 22159 bps in 2016.
• Year by year, EBITDA Margin stood at 28.98% in 2014, then slumped by 712 bps to 235.48% in 2015, then gained by 12 bps to 207.5% in 2016.
• Per Business Quant, the three latest ODYY EBITDA Margin figures stand at 207.5% (Q3 2016), 13.88% (Q2 2016), and 235.48% (Q2 2015).